sk&f 99085 has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bentzen, CL; Chantry, A; Croucher, PI; Edwards, CM; Guyon-Gellin, Y; Mueller, G; Niesor, EJ; Perry, M; Roelofs, AJ; Russell, RG; Van Camp, B; Vanderkerken, K | 1 |
1 other study(ies) available for sk&f 99085 and Bone Loss, Osteoclastic
Article | Year |
---|---|
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Topics: Animals; Apoptosis; Bone Density; Bone Resorption; Diphosphonates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Multiple Myeloma; Osteoclasts; Paraproteins; Tumor Cells, Cultured | 2007 |